09-24-Daily AI News Daily

Today’s Summary 

Scientists discover new anti-aging target PTCHD4—knocking it out lets mice live several months longer without gray fur, mechanism involves AKT pathway.

AI drug company Basecamp raises $140M to advance in vivo gene editing, with Anthropic and Nvidia betting on this track.

Nature unveils molecular mechanism of calorie restriction extending lifespan in fruit flies, but human applications are still far off—don't rush into dieting.

⚡ Quick Navigation

💡 Tip: Want to try GPT, Claude, Gemini, Codex, Cursor, Grok and other tools mentioned in the article, but don’t want to deal with overseas payments, registration, quotas and tutorials? Visit Aivora to choose official accounts, mirrors, Cursor plans or relay access by scenario. Self-service ordering on the official site, instant card delivery.

Today’s AI Life Sciences News

👀 In One Sentence

Scientists discover new anti-aging target PTCHD4—knocking it out extends mouse lifespan by several months without gray fur

🔑 3 Key Terms

#CellularSenescence #Anti-AgingTarget #LongevityGene

🔥 Top 10 Stories

1. Discovery of Entirely New Anti-Aging Target: PTCHD4 Knockout Extends Mouse Lifespan by Months

PTCHD4 is a protein that’s been barely studied before. The research team found it’s highly expressed in senescent cells, appearing in sync with the classic senescence marker p16. More importantly: mice with PTCHD4 knocked out lived several months longer than normal mice and didn’t develop gray fur. In a lung fibrosis model, mice lacking PTCHD4 maintained better lung function with less immune infiltration. Mechanistically, PTCHD4 promotes senescence by activating the AKT signaling pathway—a known pathway, but PTCHD4 itself is a newly discovered upstream switch.

The research is still at the animal experiment stage. Whether PTCHD4 can become a reliable intervention target, whether it has side effects, and how to precisely inhibit it all need follow-up validation. Currently, we can only say it’s strongly correlated with aging, not that it’s the sole key factor for lifespan extension.

Source Type: Research news report / Evidence Stage: Animal experiments (mice) / Credibility: Medium

Advantages of AI Building Blocks

2. Link Between Ultra-Processed Foods and Brain Aging: Scientific Progress and Cognitive Risk

Ultra-processed foods containing dyes, additives, and preservatives are now everywhere. Owen Carmichael at Louisiana State University’s Pennington Biomedical Research Center is systematically studying their relationship with brain aging. There’s already some consensus on metabolic health impacts, but long-term effects on cognitive function and neurodegenerative diseases remain unclear.

Research is ongoing with no specific data or conclusions published yet. The challenge with this type of epidemiological research is: it’s hard to isolate the independent effect of ultra-processed foods from overall dietary patterns, lifestyle, and socioeconomic factors. Even if correlations are found, causal relationships can’t be directly inferred.

Source Type: Research news report / Evidence Stage: Research in progress, no results published / Credibility: Low (no supporting data yet)

3. AI Drug Company Basecamp Research Completes $140M Series C Funding with Anthropic and Nvidia Participating

Basecamp uses its biological foundation model EDEN to design in vivo cell therapies—directly reprogramming cells inside patients rather than modifying them ex vivo and reinfusing like current CAR-T. EDEN’s training data comes from the company’s “trillion gene atlas,” covering biodiversity samples from over 30 countries across seven continents. Preprints show EDEN-generated large serine recombinases have a 63.2% functional hit rate, with 50% active in human cells, achieving therapeutic-grade CAR insertion.

Anthropic participated through its $100M Anthology Fund, and Nvidia’s venture arm NVentures also joined. Funding will be used to train the next generation EDEN model and advance preclinical research. Currently, there’s only in vitro cell data and animal experiment support—human clinical trials are still distant. The safety, off-target effects, and long-term impacts of in vivo gene editing all need rigorous validation.

Source Type: Business news report / Evidence Stage: Funding announcement, preclinical research / Credibility: Medium (business progress clear, technical validation pending)

4. Fruit Fly Study Reveals: Key Protein Lsp2 Regulates Lifespan Through mTORC1 in Dietary Restriction

Caloric restriction extends fruit fly lifespan, but the molecular mechanism has been unclear. This Nature-published study found that Lsp2 (lipid storage protein 2) is a key node connecting the mTORC1 signaling pathway and TOP mRNA translation. mTORC1 is a core switch regulating cell growth and metabolism, while TOP mRNA translation controls ribosomal protein synthesis. Research shows that during caloric restriction, Lsp2 expression increases, extending lifespan by suppressing mTORC1 activity and reducing protein synthesis.

This is a fruit fly experiment and can’t be directly extrapolated to humans. However, the mTORC1 pathway is highly conserved in mammals. Whether Lsp2’s human homolog has similar functions and can become an intervention target warrants follow-up research. Currently, we can only say it’s part of the caloric restriction lifespan extension mechanism in fruit flies—this doesn’t justify recommending human dietary intervention programs.

Source Type: Peer-reviewed paper (Nature) / Evidence Stage: Animal experiments (fruit flies) / Credibility: High (solid mechanistic research, but species extrapolation requires caution)

5. Targeting BIRC6 Reverses Hematopoietic Stem Cell Aging and Immunosenescence

BIRC6 is an apoptosis inhibitor protein. Research found that inhibiting BIRC6 can restore aged hematopoietic stem cells to a youthful state and improve immune function. During aging, hematopoietic stem cells have reduced self-renewal capacity and skewed myeloid differentiation, leading to decreased immunity and increased inflammation. Targeting BIRC6 can partially reverse these changes.

Animal experiments show clear effects, but human trials haven’t begun yet. Hematopoietic system interventions require extreme caution—ensuring normal hematopoiesis isn’t damaged while avoiding potential tumor risk (apoptosis inhibition is closely related to cancer). Currently, we can’t conclude that inhibiting BIRC6 can be safely used for human anti-aging.

Source Type: Peer-reviewed paper / Evidence Stage: Animal experiments, mechanistic research / Credibility: Medium (clear mechanism, clinical application pending validation)

6. Role of Senescent Cells in Kidney Aging, Injury, and Fibrosis

This is a review systematically examining the role of senescent cells in kidney disease. Senescent cells secrete pro-inflammatory factors, growth factors, and proteases (collectively called SASP), accelerating kidney fibrosis and functional decline. Animal experiments clearing senescent cells show they can reduce kidney damage and slow chronic kidney disease progression.

But a review doesn’t equal clinical evidence. There are currently no senescent cell clearance therapies for kidney disease in clinical trials. Moreover, not all senescent cells are harmful—some play roles in tissue repair. How to precisely identify and selectively clear harmful senescent cells is an urgent problem to solve.

Source Type: Peer-reviewed review (Nature Reviews Nephrology) / Evidence Stage: Summary of animal experiments, no human trials / Credibility: Medium (high-quality review, but lacks human evidence)

7. Earth’s Magnetic Field May Affect Cellular Energy Production and Aging Process

New research from the University of Nottingham suggests Earth’s magnetic field may affect cellular energy production, exercise performance, and even lifespan. This is a surprising direction—conventionally, geomagnetic field strength is considered too weak to significantly affect biochemical processes. Researchers speculate it may work through the radical pair mechanism, a quantum effect sensitive to magnetic fields in certain chemical reactions.

This is only a preliminary observation with unclear mechanism and no specific data. Even if the geomagnetic field does have an effect, how significant the actual physiological meaning is and whether intervention methods can be developed are unknown. This type of research is better suited as a basic science lead rather than a basis for anti-aging programs.

Source Type: Research news report / Evidence Stage: Early exploratory research / Credibility: Low (lacks data and mechanism validation)

8. DNMT3A and TET2 Mutations Trigger Inflammation Through Different Pathways in Clonal Hematopoiesis

Clonal hematopoiesis is an age-related phenomenon: mutated hematopoietic stem cells expand, forming numerous blood cells carrying the same mutation. DNMT3A and TET2 are the two most common mutated genes. GeroScience-published research found that while both mutations lead to inflammation, their mechanisms differ—they affect different parts of epigenetic regulation, activating different inflammatory pathways.

Understanding these differences helps develop precision intervention strategies. But whether clonal hematopoiesis itself needs intervention is still debated: most carriers remain asymptomatic throughout life, with only a small portion developing blood disorders. There are currently no approved therapies for clonal hematopoiesis, only regular monitoring.

Source Type: Peer-reviewed paper (GeroScience) / Evidence Stage: Mechanistic research, human cells and mouse models / Credibility: Medium (solid mechanistic research, clinical significance pending clarification)

9. Number of Patients 55+ with Opioid Use Disorder Doubles in Eight Years

A new report from the Ontario Drug Policy Research Network shows that between 2017 and 2025, the number of people aged 55 and older seeking medical care for opioid use disorder (OUD) more than doubled. This isn’t AI or life science research, but public health data. Rising OUD risk in older adults may be related to chronic pain management, polypharmacy, cognitive decline, and other factors.

This suggests the need to strengthen alternative approaches to pain management in older adults, improve prescription monitoring, and provide age-appropriate addiction treatment services. However, this belongs to public health policy and isn’t directly related to core topics like AI drug discovery and biotechnology in this daily report.

Source Type: Public health report / Evidence Stage: Epidemiological data / Credibility: High (official statistical data)

Note: This item doesn’t belong to the core content of AI + life sciences intersection, included only as background information on healthy aging.

10. Family Conflicts in Dementia Care and Importance of Advance Planning

Researchers conducted focus group interviews with family caregivers of dementia patients, finding that the caregiving process often exposes hidden family conflicts—about finances, decision-making authority, and caregiving responsibility allocation. Advance care planning and clarifying each party’s roles and wishes can reduce later conflicts.

This is sociology and nursing research, unrelated to AI technology and biomedical interventions. But dementia is a core disease of interest in longevity studies, and understanding caregiving realities helps design medical and social support systems that better meet actual needs.

Source Type: Qualitative research report / Evidence Stage: Focus group interviews / Credibility: Medium (qualitative research, doesn’t provide causal evidence)

Note: This item doesn’t belong to the core content of AI + life sciences intersection, included only as background information on dementia care reality.

📌 Worth Noting

[Product]

[Research]

[Other]

📎 Key Takeaways for Today

1. PTCHD4 Knockout Extends Mouse Lifespan by Months

Factual Conclusion: Research team found in mouse experiments that knocking out PTCHD4 protein extended natural lifespan by months compared to wild-type mice, without gray fur; in lung fibrosis model, mice lacking PTCHD4 maintained better lung function. Mechanistically, PTCHD4 promotes cellular senescence by activating the AKT signaling pathway.

Original Source: An Entirely New Target for Fighting Senescence

Evidence Boundaries: Animal experiments (mice), no human research. Whether PTCHD4 can become a safe and effective human anti-aging intervention target, whether it has side effects, and how to precisely inhibit it all require follow-up validation. Currently can only state PTCHD4 is strongly correlated with mouse aging; cannot recommend human anti-aging programs based on this.

2. Basecamp’s EDEN Model Achieves 50% Functional Hit Rate in In Vitro Cells

Factual Conclusion: Basecamp Research’s biological foundation model EDEN showed in preprint research that generated large serine recombinases have 50% activity in human cells, achieving therapeutic-grade CAR insertion. Company completed $140M Series C funding with Anthropic and Nvidia participating.

Original Source: Anthropic-, Nvidia-Backed Basecamp Research Raise $140M Series C Financing Toward Advancing AI-Designed Drugs

Evidence Boundaries: Preprint research (not peer-reviewed), only in vitro cell and animal experiment data, hasn’t entered human clinical trials. Safety, off-target effects, and long-term impacts of in vivo gene editing require rigorous validation; cannot consider technology clinically ready based on this.

3. Fruit Fly Study Reveals Lsp2 Regulates Lifespan Through mTORC1

Factual Conclusion: Nature-published research shows that during caloric restriction in fruit flies, Lsp2 expression increases, extending lifespan by suppressing mTORC1 activity and reducing protein synthesis. Lsp2 is a key node connecting the mTORC1 signaling pathway and TOP mRNA translation.

Original Source: Lsp2 links mTORC1 to TOP mRNA translation and lifespan in Drosophila

Evidence Boundaries: Fruit fly experiments, cannot be directly extrapolated to humans. While the mTORC1 pathway is highly conserved in mammals, whether Lsp2’s human homolog has similar functions and can become an intervention target requires follow-up research. Cannot recommend human dietary intervention programs based on this.

🔮 AI Life Sciences Trend Predictions

Senescent Cell Clearance Therapies Enter Large-Scale Clinical Trials

  • Prediction Time: Q4 2026
  • Prediction Probability: 70%
  • Prediction Basis: Today’s news shows multiple anti-aging targets (PTCHD4, BIRC6) achieved positive results in animal experiments + In the past two years, multiple early clinical trials of Senolytics (senescent cell clearance drugs) have been launched; expect more projects to enter larger-scale Phase II or III trials in Q4 this year

Basecamp’s EDEN Model Announces First Preclinical Candidate Drug

  • Prediction Time: October-November 2026
  • Prediction Probability: 60%
  • Prediction Basis: Today’s news Basecamp completes $140M Series C funding + Company preprints already show EDEN’s effectiveness in in vitro cells; after financing, specific pipeline progress is usually announced within 1-2 months to boost confidence

AI-Driven mRNA Vaccine Design Platform Gains Regulatory Recognition

  • Prediction Time: Q4 2026
  • Prediction Probability: 55%
  • Prediction Basis: Although today’s materials don’t directly mention mRNA, multiple AI biodesign platforms (including Basecamp’s EDEN) have demonstrated capability to design complex biomolecules + FDA and EMA have accelerated approval of AI-based drug discovery tools in recent years; expect first AI-designed mRNA vaccine to receive clinical trial approval this year

Large Cohort Study Results on Ultra-Processed Foods and Cognitive Decline Published

  • Prediction Time: October 2026
  • Prediction Probability: 50%
  • Prediction Basis: Today’s news Ultra-processed foods and brain aging research progress mentions LSU is conducting comprehensive research + This type of epidemiological research typically requires years of follow-up, but interim data analysis results may be published soon
09-25-Daily09-23-Daily